We are live on
!
Find out more
GGV
GG Group Ventures Portfolio holdings
AUM
$75.8M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$68.6M
AUM Growth
-$3.54M
(-4.9%)
Holding
56
Top Buys
| 1 | +$859K | |
| 2 | +$657K | |
| 3 | +$578K | |
| 4 |
ProShares Ultra S&P500
SSO
|
+$495K |
| 5 |
Schwab US Broad Market ETF
SCHB
|
+$494K |
Top Sells
| 1 | +$4.18M | |
| 2 | +$3.49M | |
| 3 | +$1.31M | |
| 4 |
ProShares Ultra QQQ
QLD
|
+$373K |
| 5 |
Direxion Daily Small Cap Bull 3x ETF
TNA
|
+$299K |
Sector Composition
| 1 | Technology | 15.14% |
| 2 | Communication Services | 2.48% |
| 3 | Financials | 1.85% |
| 4 | Consumer Discretionary | 1.82% |
| 5 | Industrials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIFA
51
All In FutureTech Alliance Inc
AIFA
$14.7M
| – | – |
-53,829
|
|
||
|
JBIO
52
Jade Biosciences
JBIO
$1.35B
| – | – |
-374
|
|
||
53
Direxion Daily MSCI India Bull 2X ETF
INDL
$58.2M
| – | – |
-19,058
|
|
||
54
Rekor Systems
REKR
$90.6M
| – | – |
-13,513
|
|
||
55
ProShares UltraPro Russell2000
URTY
$370M
| – | – |
-5,992
|
|
||
|
VERV
56
DELISTED
Verve Therapeutics
VERV
| – | – |
-14,599
|
|